Navigation Links
Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication
Date:7/22/2014

Lawrence, KS (PRWEB) July 22, 2014

Biofeedback – When a behavioral problem such as attention-deficit hyperactivity disorder (ADHD) is diagnosed, selecting medication to best treat it can become a matter of trial and error. Analyzing brain patterns by using electroencephalography (EEG) can help predict which medicine will offer the best result and thus lower the risk of adverse drug events.

The article “Medication Prediction with Electroencephalography Phenotypes and Biomarkers” in the current issue of the journal Biofeedback offers evidence that quantitative EEG assessment can refine the selection of medications by detecting brain patterns. Author Jay Gunkelman uses the example of a 7-year-old child diagnosed with ADHD.

Following current clinical standards, a patient would be diagnosed with ADHD based on behavioral observations as described in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Although this approach defines a problem, it does not predict effective therapy.

Typically, the next step would be to determine which medication would successfully treat the behavior. For ADHD, the options include stimulants, anticonvulsants, antidepressants, and channel blockers—a diverse range of pharmaceutical choices for a single diagnostic cluster. Trying one drug, then another, brings the risk of adverse drug events or severe side effects for the child being treated for ADHD.

The author proposes that quantitative EEG patterns can provide a more reliable basis for medication selection than diagnostic category. Individuals with the same symptom-based diagnoses can show differing patterns of brain dysfunction. Using these neurophysiological indicators can lead to a more accurate selection of treatment and eliminate the trial-and-error approach.

This application of quantitative EEG is an evidence-based approach to medicine. This article summarizes the EEG’s neurophysiological indicators for the medication classes indicated for ADHD, based on the author’s 43 years of experience in the field and outcomes from psychiatric practices.

Although the fields of pharmacology and EEG intersected about 50 years ago, the use of EEG is currently outside clinical practice standards in psychiatry. Change is coming, however, as the DSM-V approach is being abandoned in favor of predictors of treatment efficacy.

Full text of the article, “Medication Prediction with Electroencephalography Phenotypes and Biomarkers,” Biofeedback, Vol. 42, No. 2, 2014, is available at http://www.aapb-biofeedback.com/doi/full/10.5298/1081-5937-42.2.03.

###

About Biofeedback
Biofeedback is published four times per year and distributed by the Association for Applied Psychophysiology and Biofeedback. AAPB’s mission is to advance the development, dissemination, and utilization of knowledge about applied psychophysiology and biofeedback to improve health and the quality of life through research, education, and practice. For more information about the association, see http://www.aapb.org.

Read the full story at http://www.prweb.com/releases/EGG/medication/prweb12026852.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. PharmSource CMO-CDMO Database Expands Coverage to Include Approved Pharmaceutical Products: Intelligence Resource for Analyzing Bio/Pharmaceutical Contract Manufacturing
2. Lab Expertise Tapped to Understand How the Brain Retrieves Memories
3. Studies Show Pterostilbene Shows Promise for Anti-Aging and Maintaining Healthy Brain
4. Greathouse Books Released: Doc, I Want My Brain Back - My HBOT Miracle and Offers 22% to Help Stop the 22 Veteran Suicides Occurring Every Day
5. Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat Brain Cancer
6. Cynde Margritz Finds Hope After Brain Injury With Neurofeedback
7. SRI International Scientists Discover Brain Circuit Activated during Sleep
8. Neural prosthesis restores behavior after brain injury
9. National Brain Tumor Society Announces the Defeat GBM Research Collaborative’s Project Plans and Investigator Teams
10. BHR Pharma Engages Particle Sciences to Develop Nasal Progesterone for Traumatic Brain Injury
11. Chaotic physics in ferroelectrics hints at brain-like computing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... China , Feb. 4, 2016 Beike ... and various medical institutions attended a ceremony in late ... integrative, personalized cell therapy in 2016. ... "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" was ... Regional Cell Production Center, both subsidiaries of Beike Biotechnology ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. 4, ... and the "Company"), a biopharmaceutical company focused on the development ... will present at the 18 th Annual BIO ... at 10:00 a.m. EST in New York, NY ... and CEO, will provide an update on the ongoing clinical ...
(Date:2/4/2016)... Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Conference 2016, to be held February 8-9, 2016, at ... 2016 Disruptive Growth & Healthcare Conference, taking place in ... 2016. James Sapirstein , Chief Executive Officer ...
(Date:2/4/2016)... BEIJING , Feb. 4, 2016 Sinovac ... ), a leading provider of biopharmaceutical products in ... committee of its board of directors received on February ... 3, 2016, from a consortium comprised of PKU V-Ming ... Sinobioway Biomedicine Co., Ltd., CICC Qianhai Development ( ...
Breaking Biology Technology:
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
(Date:1/22/2016)... DUBLIN , January 22, 2016 ... has announced the addition of the  ... to their offering. --> ... of the  "Global Behavioral Biometric Market ... --> Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ...
Breaking Biology News(10 mins):